EP 4028056 A1 20220720 - METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS AND ANTI-PERIOSTIN ANTIBODIES
Title (en)
METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS AND ANTI-PERIOSTIN ANTIBODIES
Title (de)
VERFAHREN ZUR BEHANDLUNG VON KREBS DURCH VERWENDUNG VON PD-1-AXIS-INHIBITOREN UND ANTI-PERIOSTIN-ANTIKÖRPERN
Title (fr)
MÉTHODES DE TRAITEMENT DU CANCER PAR L'UTILISATION D'INHIBITEURS DE L'AXE PD-1 ET D'ANTICORPS ANTI-PÉRIOSTINE
Publication
Application
Priority
- US 201962899066 P 20190911
- CA 2020051164 W 20200827
Abstract (en)
[origin: WO2021046634A1] Described herein are methods of treating cancer comprising administering to the individual (a) a PD-1 axis inhibitor; and (b) an inhibitor of periostin.
IPC 8 full level
A61K 39/395 (2006.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP KR US)
A61K 45/06 (2013.01 - KR); A61P 1/00 (2017.12 - US); A61P 13/10 (2017.12 - US); A61P 35/00 (2017.12 - EP KR US); C07K 16/18 (2013.01 - EP KR US); C07K 16/2818 (2013.01 - EP KR US); A61K 2039/505 (2013.01 - EP KR); A61K 2039/507 (2013.01 - EP KR US); A61K 2039/545 (2013.01 - US); C07K 2317/24 (2013.01 - US); C07K 2317/56 (2013.01 - EP); C07K 2317/565 (2013.01 - EP US); C07K 2317/622 (2013.01 - EP KR); C07K 2317/76 (2013.01 - EP); C07K 2317/92 (2013.01 - EP KR US); C07K 2319/30 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2021046634 A1 20210318; WO 2021046634 A8 20220224; AU 2020345655 A1 20220224; BR 112022001985 A2 20220510; CA 3148291 A1 20210318; CN 114364400 A 20220415; EP 4028056 A1 20220720; EP 4028056 A4 20231011; JP 2022547550 A 20221114; KR 20220062056 A 20220513; MX 2022003001 A 20220407; TW 202124432 A 20210701; US 2023030597 A1 20230202
DOCDB simple family (application)
CA 2020051164 W 20200827; AU 2020345655 A 20200827; BR 112022001985 A 20200827; CA 3148291 A 20200827; CN 202080063265 A 20200827; EP 20862817 A 20200827; JP 2022515822 A 20200827; KR 20227011867 A 20200827; MX 2022003001 A 20200827; TW 109131037 A 20200910; US 202017641825 A 20200827